Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GERN
#2206
Geron Corporation - Common Stock
1.2
5
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-17.22%
6 month change
+8.70%
Year Change
-14.97%
Previous Close
1.2
5
Open
1.2
5
Low
1.2
5
High
1.2
5
Volume
103
Markets
US Stock Market
Healthcare
GERN
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
318.53 M
323.73 M
508.72 M
546.06 M
636.9 M
640.54 M
641.52 M
Valuation ratios
Enterprise value
520.58 M
409.91 M
1.22 B
1.18 B
2.34 B
887.51 M
884.92 M
Price to earnings ratio
—
—
-6.49
-6.69
-13.11
-10.15
-11.82
Price to sales ratio
—
—
1 533.36
5 152.66
1 339.75
—
—
Price to cash flow ratio
—
—
-7.17
7.28
10.46
-7.93
-0.01
Price to book ratio
—
—
11.42
4.93
8.16
3.9
0
Enterprise value to EBITDA ratio
-6.73
-3.58
-8.79
-5.79
-9.04
-3.44
—
Profitability ratios
Return on assets %
-0.28
-0.51
-0.74
-0.47
-0.29
-0.15
-0.01
Return on equity %
-0.36
-0.92
-1.77
-0.74
-0.62
-0.37
-0.02
Return on invested capital %
-620.94
-920.4
-1 542
-1 192.63
-530.59
-63.8
—
Gross margin %
100
100
100
100
100
—
100
Operating margin %
-30.4 K
-8 183.7
-23.25 K
-81.83 K
10.18 K
—
0.3
EBITDA margin %
-30.59 K
-8 221.82
-23.19 K
-86.08 K
15.17 K
—
-1.21
Net margin %
-29.89 K
-8 335.39
-23.81 K
-77.69 K
10.23 K
—
-7.03
Liquidity ratios
Quick ratio
—
—
—
—
5.12
3.62
4.96
Current ratio
6.46
4.11
2.35
3.16
5.56
4.66
6.78
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.01
0
0
-0
0
0.09
Solvency ratios
Debt to assets ratio
0.09
0.22
0.27
0.21
0.28
0.21
0.22
Debt to equity ratio
0.11
0.39
0.64
0.33
0.59
0.53
0.52
Long term debt to total assets ratio
0.12
0.28
-0
-0
0.32
0.3
0.31
Long term debt to total equity ratio
0.16
0.5
-0.01
-0
0.68
0.75
0.72
Per share metrics
Operating cash flow per share
—
—
-0.33
-0.29
-0.34
-0.17
-94.07
EBIT per share
—
—
-0.36
-0.34
-0.39
-0.38
—
EBITDA per share
—
—
-0.36
-0.36
-0.4
-0.39
—
Total debt per share
—
—
0.13
0.14
0.26
0.18
179.02
Cash per share
—
—
0.45
0.58
0.63
0.12
102.92
Net current asset value per share
—
—
0.47
0.6
0.76
0.78
744.77
Tangible book value per share
—
—
0.21
0.43
0.43
0.34
342.27
Working capital per share
—
—
0.27
0.41
0.62
0.61
634.86
Book value per share
—
—
0.21
0.43
0.43
0.34
342.27
Geron Corporation - Common Stock
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
News
Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans
Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Geron at TD Cowen: Strategic Growth and Market Expansion
Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)
Geron Corporation (GERN) Q4 2025 Earnings Call Transcript
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
Geron earnings missed by $0.02, revenue fell short of estimates
Insmed (INSM) Reports Q4 Loss, Lags Revenue Estimates